Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferrous aspartoglycinate is an **iron-amino acid chelate** where iron is complexed with aspartic acid and glycine. It is primarily used as an oral iron supplement to treat and prevent **iron deficiency and iron deficiency anemia**. The chelated structure enhances iron bioavailability and absorption in the gastrointestinal tract, improves tolerability, and reduces gastrointestinal side effects common with traditional iron salts. Once absorbed, the iron participates in hemoglobin synthesis, supporting oxygen transport and alleviating anemia symptoms. It is particularly beneficial for patients with poor tolerance to other iron formulations, including pregnant women, menstruating women, and those with chronic illnesses[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous aspartoglycinate.